Brittain N, Higgins N, Barber M, Choi W, Carter A, Gardner J
School of Psychological Sciences, Monash University, 770 Blackburn Rd, Clayton Melbourne, VIC, 3800, Australia.
Brown University, Providence, RI, 02912, USA.
J Bioeth Inq. 2025 Aug 7. doi: 10.1007/s11673-025-10454-3.
The rapid growth in psychedelic research raises novel ethical challenges for both research and psychedelic-assisted therapy. Despite these challenges, there is no consensus among researchers, clinicians, patients, and regulators on how these ethical issues may be avoided or managed. This study aimed to identify key ethical issues in psychedelic research and practice in the literature. A scoping review was performed, identifying fifty-one relevant articles. Content analysis revealed five main ethical concerns in the literature: 1) standards of practice, 2) equity, 3) integrity, 4) cultural appropriation, and 5) epistemic justice. A consultation workshop highlighted several key concerns that were neglected in the literature: 1) post-trial care, 2) lack of consensus on models of care and psychedelic practitioner competencies, and 3) how current research and its associated ethical issues will be translated into practice. Based on these findings the following future directions are recommended: designing clear competency frameworks, increased consultation with Indigenous and priority populations (e.g. ethnic and cultural minorities, under-served groups), guidelines for Indigenous recognition, management of post-trial care in clinical trials, and adequate governance of psychedelic prescribing practices.
迷幻剂研究的迅速发展给研究和迷幻剂辅助治疗带来了新的伦理挑战。尽管存在这些挑战,但研究人员、临床医生、患者和监管机构对于如何避免或管理这些伦理问题尚未达成共识。本研究旨在确定文献中迷幻剂研究与实践中的关键伦理问题。我们进行了一项范围综述,确定了51篇相关文章。内容分析揭示了文献中的五个主要伦理关注点:1)实践标准,2)公平性,3)诚信,4)文化挪用,以及5)认知正义。一次咨询研讨会突出了文献中被忽视的几个关键问题:1)试验后护理,2)护理模式和迷幻剂从业者能力缺乏共识,以及3)当前研究及其相关伦理问题将如何转化为实践。基于这些发现,建议未来采取以下方向:设计明确的能力框架,加强与原住民和重点人群(如少数族裔和文化群体、服务不足群体)的协商,制定原住民认可指南,管理临床试验中的试验后护理,以及对迷幻剂处方实践进行充分治理。